November 6th, 2018 by aveciapharma
Avecia Pharma's management team returned from a successful week in Cherry Hill, New Jersey, attending the American Pharma Outsourcing Summit 2018. As a special thanks for speaking at the event, we received a donation in Avecia Pharma's honor to UNICEF USA from the event organizers, Generis Group. This...
Read Full Story »
Tags: presentations, industry events
Posted in: Company News
April 17th, 2018 by aveciapharma
HEADLINE
Cell-Based Assays in a CGMP Environment: Approaches for Clinical and Commercial Stability Studies, New Webinar Hosted by Xtalks.
SUB-HEADLINE
Presentation to highlight the approaches used in developing consistent cell-based potency assays meeting regulatory expectations (USP and ) and...
Read Full Story »
Tags: presentations, Xtalks, compliance and guidelines, GMP environment, cell-based assays, regulations
Posted in: Press Release
February 1st, 2018 by aveciapharma
CAMBRIDGE, MA – Nitto Denko Avecia, Inc. (Avecia), a leader in oligonucleotide API (active pharmaceutical ingredient) manufacturing, announced today the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible...
Read Full Story »
Tags: international, industry events, announcements, oligonucleotide
Posted in: Company News, Press Release
January 15th, 2018 by aveciapharma
NITTO AVECIA PHARMA SERVICES APPOINTS RAYMOND KACZMAREK AS PRESIDENT
IRVINE, CA – Nitto Avecia Pharma Services, Inc. (Avecia Pharma), a leading CGMP contract development and manufacturing organization (CDMO), announced today that it has appointed Raymond Kaczmarek to the position of President....
Read Full Story »
Tags: GMP environment, announcements
Posted in: Company News, Press Release